International Clinical Trial: A Multicenter, Randomized, Controlled Clinical Study to Compare of Efficacy and Safety Between Tretinoin Capsules Combined with Arsenic Agents and Tretinoin Tablets Combined with Arsenic Agents in the Treatment of Low-Risk Acute Promyelocytic Leukemia

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119427) titled 'A Multicenter, Randomized, Controlled Clinical Study to Compare of Efficacy and Safety Between Tretinoin Capsules Combined with Arsenic Agents and Tretinoin Tablets Combined with Arsenic Agents in the Treatment of Low-Risk Acute Promyelocytic Leukemia' on Feb. 27.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Beijing Chao-Yang Hospital, Capital Medical University

Condition: Acute Promyelocytic Leukemia

Intervention: Trial Group:Retinoid acid capsules 25mg/m^2/d, oral twice daily Arsenic trioxide 0.16mg/m^2/d, intravenous infusion (or Compound Huangdai tablets 60mg/kg/d, oral) Co...